Phase I dendritic cell p53 peptide vaccine for head and neck cancer.-论文-万方医学网

作者： Patrick J,Schuler ^[1] ; Malgorzata,Harasymczuk ; Carmen,Visus ; Albert,Deleo ; Sumita,Trivedi ; Yu,Lei ; Athanassios,Argiris ; William,Gooding ; Lisa H,Butterfield ; Theresa L,Whiteside ; Robert L,Ferris

作者单位： Authors' Affiliations: Cancer Immunology Program; Biostatistics Facility, University of Pittsburgh Cancer Institute; Departments of Pathology and Otolaryngology, University of Pittsburgh School of Medicine; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Medicine, Hematology/Oncology, University of Texas-San Antonio Cancer Center, San Antonio, Texas; and Department of Otolaryngology, University of Ulm, Germany. ^[1]

主题词成年人(Adult);老年人(Aged);癌症疫苗(Cancer Vaccines);癌, 鳞状细胞(Carcinoma, Squamous Cell);细胞因子类(Cytokines);树突细胞(Dendritic Cells);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);免疫表型分型(Immunophenotyping);免疫疗法(Immunotherapy);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);肽碎片(Peptide Fragments);表型(Phenotype);T淋巴细胞, 细胞毒性(T-Lymphocytes, Cytotoxic);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);治疗结果(Treatment Outcome);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53);接种(Vaccination)

DOI 10.1158/1078-0432.CCR-13-2617

PMID 24583792

发布时间 2024-05-02

检索历史清除

Phase I dendritic cell p53 peptide vaccine for head and neck cancer.

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase I dendritic cell p53 peptide vaccine for head and neck cancer.

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除